NCT00258050
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Lebanon, New Hampshire, United States
- GSK Investigational Site Chapel Hill, North Carolina, United States
Clinical trial condition
Neoplasms, Breast
Explore clinical trials studying Neoplasms, Breast. Study availability and eligibility vary by location and protocol.
51 public trials
1 recruiting study
Neoplasms, Breast trial results
NCT00169533
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Indianapolis, Indiana, United States
- GSK Investigational Site Detroit, Michigan, United States
- GSK Investigational Site Lebanon, New Hampshire, United States
- GSK Investigational Site Albuquerque, New Mexico, United States
NCT00388076
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site New Brunswick, New Jersey, United States
- GSK Investigational Site Cleveland, Ohio, United States
- GSK Investigational Site Nashville, Tennessee, United States
NCT00650910
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Albuquerque, New Mexico, United States
- GSK Investigational Site Edmonton, Alberta, Canada
- GSK Investigational Site Seodaemun-gu, Seoul, South Korea
- GSK Investigational Site Seoul, South Korea
NCT00849329
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Greenville, South Carolina, United States
- GSK Investigational Site Seoul, South Korea
- GSK Investigational Site Songpa-gu, Seoul, South Korea
- GSK Investigational Site Hospitalet de Llobregat (Barcelona), Spain
NCT00722293
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +20 more
- Locations
-
- GSK Investigational Site Milan, Lombardy, Italy
- GSK Investigational Site Bellinzona, Switzerland
- GSK Investigational Site Lausanne, Switzerland
- GSK Investigational Site Sankt Gallen, Switzerland
NCT00821054
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Buffalo, New York, United States
- GSK Investigational Site Greenville, South Carolina, United States
- GSK Investigational Site Edmonton, Alberta, Canada
- GSK Investigational Site Montreal, Quebec, Canada
NCT00359190
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Miami, Florida, United States
- GSK Investigational Site Durham, North Carolina, United States
- GSK Investigational Site Allentown, Pennsylvania, United States
- GSK Investigational Site Pittsburgh, Pennsylvania, United States
Completed
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
NCT00996762
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Scottsdale, Arizona, United States
- GSK Investigational Site Tucson, Arizona, United States
- GSK Investigational Site Washington D.C., District of Columbia, United States
- GSK Investigational Site Fort Myers, Florida, United States
NCT00111787
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Miami, Florida, United States
- GSK Investigational Site Chicago, Illinois, United States
- GSK Investigational Site Zion, Illinois, United States
- GSK Investigational Site Houston, Texas, United States